From the Food and Drug Administration.
Nightingale
S L
SL
D000690:Amyotrophic Lateral Sclerosis / Q000188:drug therapy*; D004348:Drug Labeling; D015507:Drugs, Investigational / Q000627:therapeutic use*; D006801:Humans; D011358:Product Surveillance, Postmarketing; D019782:Riluzole; D013806:Theophylline; D013844:Thiazoles / Q000627:therapeutic use*; D014481:United States; D014486:United States Food and Drug Administration
D015507:Drugs, Investigational; D013844:Thiazoles; D019782:Riluzole; D013806:Theophylline